Skip to main content

Table 3 Logistic regression of the association between aortic stiffness and clinical factors with CVD events

From: Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes

  Hazard ratio 95% CI P value
AAD 0.49 (0.25; 0.95) 0.01
DAD 0.70 (0.41; 1.20) 0.19
PWV 1.07 (0.90; 1.26) 0.45
Age 1.05 (1.00; 1.10) 0.07
Gender 0.19 (0.02; 1.52) 0.12
Body mass index 0.97 (0.86; 1.09) 0.62
Duration of diabetes 0.99 (0.88; 1.10) 0.80
HbA1c 0.98 (0.95; 1.02) 0.35
Median HbA1c since diagnosis 1.01 (0.97; 1.04) 0.75
Maximum HbA1c since diagnosis 1.00 (0.97; 1.02) 0.74
Microalbuminuria 2.19 (0.77; 6.16) 0.13
24 h systolic BP 1.02 (0.99; 1.06) 0.18
24 h diastolic BP 1.01 (0.95; 1.06) 0.80
Total cholesterol 0.89 (0.56; 1.43) 0.64
Smoking 3.38 (1.03; 11.15) 0.05
Serum aldosterone 1.00 (0.99; 1.00) 0.33
High sensitivity C reactive protein 0.99 (0.90; 1.09) 0.87
  1. Significant associations in italics
  2. CI confidence interval, AAD ascending aorta distensibility, DAD descending aorta distensibility, PWV pulse wave velocity, CVD cardiovascular disease